David O’Toole is recorded as CFO at AVITA Medical, Inc. (RCEL). The newest filing on record that lists David O’Toole as CFO at AVITA Medical, Inc. (RCEL) is dated April 22, 2026. AVITA Medical, Inc. reported in an 8-K filed June 16, 2023 that David O’Toole was appointed Chief Financial Officer, effective June 15, 2023. The proxy statement of AVITA Medical, Inc. reports total compensation of $1,532,265 for David O’Toole in fiscal 2025, including a base salary of $490,916. Disclosed compensation is on record for 4 fiscal years. David O’Toole has spoken on 13 earnings calls across 1 company, most recently for AVITA Medical, Inc. on August 6, 2026. AVITA Medical, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at AVITA Medical, Inc. includes Cary Vance (CEO, Chairman and Board Member), Jan Stern Reed (Chairman and Board Member), David O'Toole (CFO) and 7 others.
“AVITA Medical, Inc. (the “Company”) entered into an Executive Employment Agreement (the “Agreement”) with David O’Toole with an effective date of June 15, 2023 (the “Effective Date”), pursuant to which Mr. O’Toole will serve as the Company’s Chief Financial Officer.”
AVITA Medical, Inc. Form 8-K, filed June 16, 2023
· Read the filing
David O’Toole on recent calls
“I will use my prepared remarks to look at how our strong commercial performance is flowing through the business, particularly across operating leverage, cash generation and our path to cash flow break-even turning to the financials on slide 4 let me start with revenue as Kerry indicated revenue increased approximately…”
“As Kerry outlined, the fourth quarter marked the close of a year of stabilization for AVIDA and a transition into a more execution-focused phase of the business.”
“As Cary described, the third quarter was an inflection point for AVITA, one that reflected the challenges we faced this year, but also the actions now underway to set the stage for improvement.”
